Inhibition of PKC-δ reduce rhabdomyolysis-induced acute kidney injury

Area of Science:

• Nephrology
• Molecular Biology
• Biochemistry

Background:

• Rhabdomyolysis-induced acute kidney injury (AKI) is a serious condition with incompletely understood mechanisms.
• Myoglobinuria, a hallmark of rhabdomyolysis, is implicated in kidney damage, but the precise molecular pathways are unclear.

Purpose of the Study:

• To elucidate the role of protein kinase Cδ (PKC-δ) in the pathogenesis of rhabdomyolysis-induced AKI.
• To investigate the therapeutic potential of targeting PKC-δ for AKI treatment.

Main Methods:

• Established cell and murine models of rhabdomyolysis-induced AKI using myoglobin and glycerin.
• Assessed PKC-δ activation, apoptosis, and inflammatory markers (TNF-α, IL1-β).
• Utilized the PKC-δ inhibitor rottlerin and analyzed p38MAPK and ERK1/2 signaling pathways.

Main Results:

• PKC-δ was activated in both cell and murine models of rhabdomyolysis-induced AKI.
• Activated PKC-δ promoted renal cell apoptosis and increased expression of TNF-α and IL1-β.
• The detrimental effects of PKC-δ activation were reversed by rottlerin, involving modulation of p38MAPK and ERK1/2 pathways.

Conclusions:

• PKC-δ plays a critical role in mediating renal cell apoptosis during rhabdomyolysis-induced AKI.
• Targeting PKC-δ represents a promising therapeutic strategy for managing rhabdomyolysis-induced AKI.